Adagio Medical Holdings, Inc. (ADGM)

Adagio Medical Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	0.6	0.3	0.19
Revenue Growth (YoY)	100.67%	58.73%	-
Cost of Revenue	3.32	1.31	0.88
Gross Profit	-2.72	-1.01	-0.69
Selling, General & Admin	20.02	11.54	5.37
Research & Development	12.22	15.4	17.86
Operating Expenses	32.24	26.94	23.23
Operating Income	-34.96	-27.94	-23.91
Interest Expense	-2.92	-1.66	-0.14
Interest & Investment Income	0.42	0	0.04
Other Non Operating Income (Expenses)	11.62	-6.99	0.34
EBT Excluding Unusual Items	-25.84	-36.59	-23.67
Impairment of Goodwill	-30.32	-	-
Asset Writedown	-18.88	-	-
Pretax Income	-75.04	-36.59	-23.67
Net Income	-75.04	-36.59	-23.67
Net Income to Common	-75.04	-36.59	-23.67
Shares Outstanding (Basic)	-	1	1
Shares Outstanding (Diluted)	-	1	1
Shares Change (YoY)	-	1.10%	-
EPS (Basic)	-	-48.16	-31.50
EPS (Diluted)	-	-48.16	-31.50
Free Cash Flow	-31.11	-25.99	-22.9
Free Cash Flow Per Share	-	-34.20	-30.48
Operating Margin	-5806.98%	-9314.00%	-12652.38%
Profit Margin	-12465.28%	-12196.67%	-12525.40%
Free Cash Flow Margin	-5167.28%	-8661.67%	-12118.52%
EBITDA	-33.57	-27.41	-23.42
D&A For EBITDA	1.39	0.53	0.5
EBIT	-34.96	-27.94	-23.91

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q